Prolacta Bioscience salutes World Human Milk Donation Day, thanks donors who save fragile infant lives every day
Type: Press Releases
Topic(s): Donors
Study published in the journal Cell Host & Microbe offers proof of concept that a human milk-based synbiotic could allow therapeutic manipulation of the gut microbiome
Type: Press Releases
Topic(s): Clinical Studies Company Microbiome
Alecia-Jane Twigger, Ph.D., wins the Ruth A. Lawrence Investigator Award for outstanding contributions to advancing human milk science
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events
Independent, head-to-head study shows significant health benefits of early fortification associated with Prolacta Bioscience’s 100% human milk-based fortifiers compared to cow milk-based fortifiers for premature infants
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Early Fortification
Should human milk-based nutritional products for premature infants be homogenized? More research is needed, new journal article says
Type: Press Releases
Topic(s): Clinical Studies on Prolact/Humavant CR Company Pasteurization Product
Prolacta Bioscience enrolls first infant in Japan-based clinical trial to evaluate the effect of an Exclusive Human Milk Diet on growth and safety in premature infants
Type: Press Releases
Topic(s): Clinical Studies
Prolacta Bioscience Appoints Dr. Anne Beal to Board of Directors
Type: Press Releases
Topic(s): Company
Prolacta Bioscience Celebrates Prematurity Awareness Month by Recognizing Breast Milk Donors for Their Contributions to Premature Infants in the NICU
Type: Press Releases
Topic(s): Donors Helping Hands Tiny Treasures
Prolacta Bioscience Develops World’s First Test to Directly Detect Bacteria and Viruses, Including SARS-CoV-2, in Donor Breast Milk
Type: Press Releases
Topic(s): Company
